Eli Lilly and Co. And Incyte reported data from their phase 3 study of baricitinib in hospitalized COVID-19 patients.
Eli Lilly & Co. announced on Monday that it will stop a US-based clinical trial for its COVID-19 antibody treatment after data found …
Eli Lilly (LLY) and Innovent Biologics have announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug …
Eli Lilly (LLY) and Innovent Biologics have announced encouraging interim analysis data from ORIENT-11 at the virtual IASLC World Conference on Lung Cancer …
Hutchison China MediTech (HCM) and Eli Lilly (LLY) have announced an amendment to the 2013 License and Collaboration Agreement on Fruquintinib. The 2020 …
Shares in Eli Lilly & Co (LLY) jumped 13% after the drugmaker reported that the results of a late stage study of its …
Junshi Biosciences has announced that the first healthy volunteer has been dosed in a Phase I clinical study of JS016 in China. JS016 is …
Drugmaker Eli Lilly & Co (LLY) said that the U.S.
Junshi Biosciences Co Ltd said on Tuesday that it is gearing up to initiate clinical trials to test its experimental COVID-19 antibodies together …
Drugmaker Eli Lilly & Co (LLY) said the U.S.